Global Access to Biotherapeutics

Just - Evotec Biologics

We design and apply innovative technologies to dramatically expand global access to biotherapeutics. We are a CDMO offering development and manufacturing services for antibody and antibody-related therapeutics. Our integrated continuous manufacturing platforms operate within cGMP facilities that employ autonomous clean room technology for the cost-efficient production of antibodies, next-generation biologics and biosimilar products.

How We Partner

At Just – Evotec Biologics, collaboration and innovation are at the heart of everything we do. We also understand that biotherapeutics development is a unique journey and that's why we offer partnership opportunities at every step of the development phase – from discovery to market supply.

While we offer traditional CDMO fee-for-service approaches, our commitment to strategic partnership runs deep. We are always open to evaluate co-development, integrated programs and technology out-licensing opportunities.

Global Manufacturing Network

The global Just – Evotec Biologics network includes two US-based and one EU-based sites, offering biotherapeutics discovery, cell line, analytical, process development services as well as early clinical to commercial cGMP biomanufacturing services. We leverage the global Evotec network to support integrated or complementary antibody/biologics activities and benefit from Evotec's therapeutic area experts input, such as preclinical, IND-enabling tox and early stage clinical services.

More About Just - Evotec Biologics

Learn more about our mission, news, events and how we are working towards expanding access to biotherapeutics.

Partnership Spotlight

Experience the value of collaboration with Evotec and Just – Evotec Biologics. Read about the success stories created together with our partners.